
    
      DDD (lumbar disc degenerative disease ) patients who have been prescribed triple therapy
      (MBL+ MYO+ NSAIDs) over 2 weeks of triple therapy were enrolled in the study. They were asked
      to assess their overall satisfaction degree on triple therapy.
    
  